Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9
Corrigendum
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,165 | Dovepress* | 7,056+ | 1,427 | 8,483 | |
PubMed Central* | 109 | 53 | 162 | ||
Totals | 7,165 | 1,480 | 8,645 | ||
*Since 19 April 2017 |
View citations on PubMed and Google Scholar